Annual

EQS-News: Klaus Eberhardt to step down from Supervisory Board

Retrieved on: 
Wednesday, April 10, 2024

Dettingen/Erms (Germany), March 14, 2024 +++ The Chairman of the Supervisory Board of ElringKlinger AG, Klaus Eberhardt, today has informed the company of his intention to step down from his position upon conclusion of the upcoming Annual General Meeting on May 16, 2024, in the interests of timely succession planning.

Key Points: 
  • Dettingen/Erms (Germany), March 14, 2024 +++ The Chairman of the Supervisory Board of ElringKlinger AG, Klaus Eberhardt, today has informed the company of his intention to step down from his position upon conclusion of the upcoming Annual General Meeting on May 16, 2024, in the interests of timely succession planning.
  • Commenting on his decision, Klaus Eberhardt said, "ElringKlinger is very well positioned when it comes to pursuing its path of transformation.
  • Having recently turned 76, it is an opportune moment for me to pass on my Supervisory Board duties and chairmanship to younger hands."
  • Klaus Eberhardt has been a member of the Supervisory Board since May 16, 2013, and has held the position of Chairman since May 16, 2017, succeeding Prof. Walther H. Lechler.

EQS-News: Krones plans to pay dividend of €2.20 per share for successful 2023 financial year

Retrieved on: 
Wednesday, April 10, 2024

The steeply rising demand for resource-efficient, low-emission machinery, systems and solutions will contribute significantly to the continuation of Krones’ profitable growth course.

Key Points: 
  • The steeply rising demand for resource-efficient, low-emission machinery, systems and solutions will contribute significantly to the continuation of Krones’ profitable growth course.
  • Alongside digitalisation and service quality, sustainability is a strategic focus for Krones and is the most important driver of innovation and growth.
  • Krones increased revenue by 12.2% in the financial year 2023 compared to 2022, from €4,209.3 million to €4,720.7 million.
  • The company thus exceeded the upgraded growth target of 11% to 13% published in July 2023 (previously: 8% to 11%).

EQS-News: ecotel communication ag: Growth in all segments – B2B business pick-ing up considerably

Retrieved on: 
Wednesday, April 10, 2024

The 2023 financial year was overall very positive for ecotel, with the company achieving its forecasts and even exceeding them in some cases.

Key Points: 
  • The 2023 financial year was overall very positive for ecotel, with the company achieving its forecasts and even exceeding them in some cases.
  • Having declined for several years due to transformation-related factors, revenues in the ecotel Business Customers segment increased to € 46.2 million in the 2023 financial year (previous year: € 45.6 million).
  • Revenues in the ecotel Wholesale segment increased significantly by € 13.6 million to € 60.1 million in the 2023 financial year.
  • As a result of this sales growth, the gross profit rose by € 0.7 million to € 1.9 million.

EQS-News: SAF-HOLLAND SE with record year and significantly increased dividend proposal

Retrieved on: 
Wednesday, April 10, 2024

In 2023, SAF-HOLLAND was able to increase Group sales by 34.6% to a new record of EUR 2,106.2 million (previous year: EUR 1,565.1 million).

Key Points: 
  • In 2023, SAF-HOLLAND was able to increase Group sales by 34.6% to a new record of EUR 2,106.2 million (previous year: EUR 1,565.1 million).
  • Adjusted EBIT increased significantly by 62.2% in the 2023 fiscal year, reaching EUR 202.1 million (previous year: EUR 124.6 million).
  • Free operating cash flow increased significantly by EUR 22.7 million compared to the previous year, from EUR 120.0 million to EUR 142.7 million.
  • In addition, the increased share of the aftermarket business should have a positive effect on margin development.

EQS-News: Change in the Supervisory Board of Cherry SE: Harald von Heynitz succeeds Joachim Coers

Retrieved on: 
Wednesday, April 10, 2024

Change in the Supervisory Board of Cherry SE: Harald von Heynitz succeeds Joachim Coers

Key Points: 
  • Change in the Supervisory Board of Cherry SE: Harald von Heynitz succeeds Joachim Coers
    The issuer is solely responsible for the content of this announcement.
  • Munich, April 10, 2024 - The Supervisory Board of Cherry SE will be reconstituted: Joachim Coers had resigned his mandate as of December 31, 2023.
  • Harald von Heynitz was appointed with effect from April 5 until the Annual General Meeting on June 14, 2024, by the Munich court.
  • At the same time, we would like to thank Joachim Coers for his valuable work for the Supervisory Board of Cherry SE."

Annual General Meeting 2024: Shareholders approve all proposals

Retrieved on: 
Wednesday, April 10, 2024

Glattpark (Opfikon), 26 March 2024 – On Tuesday, Implenia Ltd.’s Annual General Meeting of Shareholders approved all proposals made by the Board of Directors by a large majority.

Key Points: 
  • Glattpark (Opfikon), 26 March 2024 – On Tuesday, Implenia Ltd.’s Annual General Meeting of Shareholders approved all proposals made by the Board of Directors by a large majority.
  • Shareholders voted by a majority of 99.77% to approve an ordinary dividend payment of CHF 0.60 per share.
  • This high approval rating reflects the great trust that shareholders have in the Board and in Implenia’s strategy.
  • It focuses on client needs and on striking a sustainable balance between commercial success and social and environmental responsibility.

EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges

Retrieved on: 
Wednesday, April 10, 2024

Grünwald, 28 March 2024 – Dermapharm Holding SE ("Dermapharm"), a rapidly growing manufacturer of branded pharmaceuticals, today published its full Annual Report 2023.

Key Points: 
  • Grünwald, 28 March 2024 – Dermapharm Holding SE ("Dermapharm"), a rapidly growing manufacturer of branded pharmaceuticals, today published its full Annual Report 2023.
  • Despite a difficult macroeconomic environment, Dermapharm succeeded in maintaining its growth trajectory and hitting the upper end of the guidance range in 2023.
  • "In addition to the end of the boom phase associated with vaccine production, 2023 was also shaped by various other macroeconomic and geopolitical challenges.
  • The Annual General Meeting of Dermapharm Holding SE will take place on 27 June 2024.

SIG announces changes in the Board of Directors

Retrieved on: 
Wednesday, April 10, 2024

At the Annual General Meeting of SIG Group AG (“SIG” or “the Group”), to be held on 23 April 2024, all existing members of the Board of Directors will stand for re-election for a one-year term of office.

Key Points: 
  • At the Annual General Meeting of SIG Group AG (“SIG” or “the Group”), to be held on 23 April 2024, all existing members of the Board of Directors will stand for re-election for a one-year term of office.
  • The Board of Directors also proposes the election of Thomas Dittrich as a new member of the Board of Directors for a one-year term.
  • Prior to this, he held various high-level management positions including those of Chief Financial Officer and executive member of the Board of Directors of Shire plc.
  • Andreas Umbach is proposed for re-election as the Chair of the Board of Directors for a one-year term.

Nordea's Board resolves on transfer of shares under variable remuneration programmes

Retrieved on: 
Wednesday, April 10, 2024

Nordea Bank Abp's ("Nordea") Board of Directors has today resolved on a transfer of own shares with deviation from the shareholders' pre-emptive rights by way of a directed issuance pursuant to Nordea's variable remuneration awards.

Key Points: 
  • Nordea Bank Abp's ("Nordea") Board of Directors has today resolved on a transfer of own shares with deviation from the shareholders' pre-emptive rights by way of a directed issuance pursuant to Nordea's variable remuneration awards.
  • The resolution is based on the authorisation granted to the Board of Directors by the Annual General Meeting 2023.
  • In the share issuance, a maximum of 2,700,000 own shares held by Nordea will be transferred without consideration to participants of variable pay programmes according to the applicable terms and conditions of the programmes and regulatory requirements to settle Nordea's commitments for payment of part of variable pay in shares.
  • The shares will be transferred on or around 4 April 2024, at the earliest, in one or several instalments.

EQS-News: SINGULUS TECHNOLOGIES publishes annual financial statements 2023

Retrieved on: 
Wednesday, April 10, 2024

Kahl am Main, April 8, 2024 - The Supervisory Board of SINGULUS TECHNOLOGIES AG approved the annual financial statements, the consolidated financial statements, and the combined status report of the company for the business year 2023 on April 4, 2024, and adopted the annual financial statements.

Key Points: 
  • Kahl am Main, April 8, 2024 - The Supervisory Board of SINGULUS TECHNOLOGIES AG approved the annual financial statements, the consolidated financial statements, and the combined status report of the company for the business year 2023 on April 4, 2024, and adopted the annual financial statements.
  • The annual financial statements for 2023 were published today, April 8, 2024, on the Company's website at: https://www.singulus.com/financial-reports/.
  • SINGULUS TECHNOLOGIES, a leading supplier of machines and systems for the semiconductor industry, has received orders for several innovative TIMARIS coating systems in recent weeks.
  • For 2024, SINGULUS TECHNOLOGIES expects a significant increase in sales compared to 2023.